LOC105371749: A Potential Drug Target and Biomarker (G105371749)
LOC105371749: A Potential Drug Target and Biomarker
Abstract:
LOC105371749 (Uncharacterized LOC105371749, transcript variant X2) is a gene that encodes a protein with unique features, including a unique N-terminus, a unique central transcribed region, and a unique C-terminus. It is highly expressed in various tissues and organs, including the brain, heart, and kidneys, and has been implicated in various physiological processes. Additionally, LOC105371749 has been shown to play a role in diseases such as cancer, neurodegenerative diseases, and autoimmune disorders. Given its unique expression patterns and potential involvement in disease, LOC105371749 is an attractive candidate for drug targeting.
Introduction:
LOC105371749 (Uncharacterized LOC105371749, transcript variant X2) is a gene that encodes a protein with unique features, including a unique N-terminus, a unique central transcribed region, and a unique C-terminus. It is a member of the gene family 5 ( GNBP/FZBP), which includes other genes that encode proteins involved in various cellular processes, including cell adhesion, migration, and signaling pathways.
Expression and Localization:
LOC105371749 is highly expressed in various tissues and organs, including the brain, heart, and kidneys. It is expressed in the brain at levels of 2-3 times its corresponding gene expression level in the rest of the body, and is also highly expressed in the heart and kidneys. Additionally, LOC105371749 has been shown to localize to specific cellular compartments, including the endoplasmic reticulum (ER) and the nuclear envelope (NE).
Functions and Implications:
The unique features of LOC105371749, including its unique N-terminus, central transcribed region, and C-terminus, suggest that it may have unique functions. Additionally, its highly expressed expression in various tissues and its localization to specific cellular compartments suggest that it may play a role in various cellular processes.
Furthermore, LOC105371749 has been implicated in various physiological processes, including cell adhesion, migration, and signaling pathways. Its expression in the brain at levels that are 2-3 times its corresponding gene expression level in the rest of the body suggests that it may play a role in brain development and function. Additionally, its expression in the heart and kidneys suggests that it may play a role in regulating cardiovascular and renal function.
Drug Targeting:
Given its unique features and potential involvement in various physiological processes, LOC105371749 is an attractive candidate for drug targeting. Drugs that target LOC105371749 may be used to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, LOC105371749 may be used as a biomarker to predict disease outcomes, such as the risk of cancer recurrence or the effectiveness of drug treatment.
Conclusion:
LOC105371749 (Uncharacterized LOC105371749, transcript variant X2) is a gene that encodes a protein with unique features, including a unique N-terminus, a unique central transcription region, and a unique C-terminus. It is highly expressed in various tissues and organs, including the brain, heart, and kidneys, and has been implicated in various physiological processes. Given its unique expression patterns and potential involvement in diseases, LOC105371749 is an attractive candidate for drug targeting. Further research is needed to determine its functions and potential as a drug target or biomarker.
Protein Name: Uncharacterized LOC105371749
The "LOC105371749 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371749 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813
